-
When the first combined oral contraceptive entered the marketplace in 1960, women began taking hormonally active pills for 21 days, followed by seven days of placebo pills, or no pills at all. This 21/7 regimen resulted in regular withdrawal bleeding every month. Such regular monthly cycles are a modern phenomenon.
-
Research has been a cornerstone of contraceptive technology; the following noninclusive list includes 25 articles of note from the past 25 years. Several selections are offered by Deborah Kowal, MA, adjunct assistant professor in the Rollins School of Public Health at Emory University in Atlanta, co-author of Contraceptive Technology, and the first editor for Contraceptive Technology Update.
-
You suspect that your 17-year-old patient may have a chlamydia infection. Thanks to a nucleic acid amplification screen on a urine specimen, you are able to detect the sexually transmitted disease (STD) and report the results the next day.
-
American women are one step closer to having a contraceptive implant option with the recent Food and Drug Administration (FDA) issuance of approvable status for Implanon, the single-rod contraceptive implant from Organon (West Orange, NJ).
-
-
The ECG in the Figure was interpreted as showing sinus tachycardia with non-specific ST-T wave abnormalities. Do you agree?
-
Oseltamivir treatment of children with influenza A virus infection was associated with the selection of resistant mutants in 18%.
-
Merck announced on September 30th that it is voluntarily withdrawing rofecoxib (Vioxx) from the worldwide market.
-
Agents which alter cardiac repolarization have been associated with torsades de pointes.
-
The FDA has approved a new formulation of hydromorphone for the management of pain.
